20
Janssen Pharmaceutica Nv Beerse Be, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Bromperidol decanoate, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2003-079 - Rev 02
This Chemical Type CEP, issued on November 21, 2013, remains in force until July 13, 2022, ensuring its reliability within the pharmaceutical industry.
Substance Number 1397 associated with this CEP further emphasizes